PANTERA, YOUR TRUSTED PARTNER
FOR PRODUCTION OF Ac-225
PanTera wants to bring a new hope to cancer patients by enabling the widespread use of radiopharmaceuticals for personalised treatment of tumors.
PanTera aims to secure the large-scale production of actinium-225 (Ac-225), one of the most promising alpha-emitting radioisotopes to fight cancers by Targeted RadioTherapy (TRT). By working towards this large-scale production, PanTera’s ultimate goal is to improve the accessibility of future innovative cancer therapy based on Ac-225 and theranostics in general.
